Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,900 | 123,785 | 69,862 | 86,035 | 88,401 |
| Receivables | 10,473 | 7,800 | 17,763 | 5,372 | 2,066 |
| Inventories | 1,163 | 361 | 55 | 74 | 121 |
| Other current assets | 0 | 993 | 0 | 0 | 0 |
| TOTAL | $116,604 | $139,949 | $92,347 | $96,534 | $96,013 |
| Non-Current Assets | |||||
| PPE Net | 805 | 740 | 731 | 715 | 728 |
| Investments And Advances | 1,280 | 1,111 | 656 | 590 | 626 |
| Intangibles | 46,375 | 47,949 | 46,249 | 46,767 | 42,942 |
| Other Non-Current Assets | 5,938 | 3,791 | 4,086 | 3,557 | 3,671 |
| TOTAL | $54,397 | $53,590 | $51,721 | $51,628 | $47,966 |
| Total Assets | $171,001 | $193,540 | $144,068 | $148,163 | $143,979 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,325 | 15,896 | 9,088 | 8,297 | 10,716 |
| Accrued Expenses | 16,149 | 13,522 | 10,397 | 8,223 | 5,668 |
| Other current liabilities | 3,170 | 2,249 | 1,404 | 1,615 | 1,510 |
| TOTAL | $29,644 | $32,230 | $20,889 | $18,135 | $17,894 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,214 | 70,661 | 42,527 | 44,439 | 20,631 |
| Other Non-Current Liabilities | 10,383 | 9,207 | 6,681 | 6,951 | 7,017 |
| TOTAL | $85,011 | $85,373 | $54,288 | $56,764 | $32,786 |
| Total Liabilities | $114,654 | $117,603 | $75,177 | $74,899 | $50,680 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 236 | 225 | 240 | 224 |
| Retained earnings | N/A | -181,979 | -173,228 | -184,986 | -177,840 |
| Other shareholders' equity | 56,347 | 922 | 0 | 0 | 0 |
| TOTAL | $56,347 | $75,937 | $68,891 | $73,263 | $93,299 |
| Total Liabilities And Equity | $171,001 | $193,540 | $144,068 | $148,163 | $143,979 |